Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial
書誌事項
- 公開日
- 2015-09
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- DOI
-
- 10.1016/j.phrs.2015.05.009
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Pharmacological Research
-
Pharmacological Research 99 74-81, 2015-09
Elsevier BV